HIGHLIGHTS
- who: Rhenium . Selenium . et al. from the Société de Coordination de Recherches Thérapeutiques, Algajola, France have published the research: Antitumor activity of a rhenium (I)-diselenoether complex in experimental models of human breast cancer, in the Journal: (JOURNAL)
- what: The aim of this paper was to report the activity of Re-diselenother complex 1 (Fig 1) in experimental models of human breast tumor toward highly metastatic MDA-MB231 cancer cells in culture, and in MDA-MB231 Luc+ tumors transplanted in mice.
SUMMARY
Among Re organometallic complexes, several Re carbonyl . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.